192 related articles for article (PubMed ID: 23963146)
21. Improving observer variability in target delineation for gastro-oesophageal cancer--the role of (18F)fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography.
Vesprini D; Ung Y; Dinniwell R; Breen S; Cheung F; Grabarz D; Kamra J; Mah K; Mansouri A; Pond G; Brock K; Darling G; Knox J; Haider M; Wong RK
Clin Oncol (R Coll Radiol); 2008 Oct; 20(8):631-8. PubMed ID: 18755578
[TBL] [Abstract][Full Text] [Related]
22. Impact of the introduction of integrated PET-CT into the preoperative staging pathway of patients with potentially operable oesophageal carcinoma.
Salahudeen HM; Balan A; Naik K; Mirsadraee S; Scarsbrook AF
Clin Radiol; 2008 Jul; 63(7):765-73. PubMed ID: 18555034
[TBL] [Abstract][Full Text] [Related]
23. Combination of FDG PET/CT and contrast-enhanced MSCT in detecting lymph node metastasis of esophageal cancer.
Tan R; Yao SZ; Huang ZQ; Li J; Li X; Tan HH; Liu QW
Asian Pac J Cancer Prev; 2014; 15(18):7719-24. PubMed ID: 25292052
[TBL] [Abstract][Full Text] [Related]
24. Has integrated 18F FDG PET/CT improved staging, reduced early recurrence or increased survival in oesophageal cancer?
Torrance AD; Almond LM; Fry J; Wadley MS; Lyburn ID
Surgeon; 2015 Feb; 13(1):19-33. PubMed ID: 24206935
[TBL] [Abstract][Full Text] [Related]
25. 18F-FDG PET/CT has a high impact on patient management and provides powerful prognostic stratification in the primary staging of esophageal cancer: a prospective study with mature survival data.
Barber TW; Duong CP; Leong T; Bressel M; Drummond EG; Hicks RJ
J Nucl Med; 2012 Jun; 53(6):864-71. PubMed ID: 22582047
[TBL] [Abstract][Full Text] [Related]
26. Clinical role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in post-operative follow up of gastric cancer: initial results.
Sun L; Su XH; Guan YS; Pan WM; Luo ZM; Wei JH; Wu H
World J Gastroenterol; 2008 Aug; 14(29):4627-32. PubMed ID: 18698676
[TBL] [Abstract][Full Text] [Related]
27. FDG-PET-CT is effective in selecting patients with poor long term survivals for colorectal liver metastases.
Yip VS; Poston GJ; Fenwick SW; Wieshmann H; Athwal T; Malik HZ
Eur J Surg Oncol; 2014 Aug; 40(8):995-9. PubMed ID: 24290370
[TBL] [Abstract][Full Text] [Related]
28. Role of ¹⁸F 2-fluoro-2-deoxyglucose positron emission tomography in upper gastrointestinal malignancies.
Smyth EC; Shah MA
World J Gastroenterol; 2011 Dec; 17(46):5059-74. PubMed ID: 22171140
[TBL] [Abstract][Full Text] [Related]
29. Incremental diagnostic utility of gastric distension FDG PET/CT.
Le Roux PY; Duong CP; Cabalag CS; Parameswaran BK; Callahan J; Hicks RJ
Eur J Nucl Med Mol Imaging; 2016 Apr; 43(4):644-53. PubMed ID: 26487512
[TBL] [Abstract][Full Text] [Related]
30. Laparoscopy, computerised tomography and fluorodeoxyglucose positron emission tomography in the management of gastric and gastro-oesophageal junction cancers.
Mirza A; Galloway S
Surg Endosc; 2016 Jul; 30(7):2690-6. PubMed ID: 26487234
[TBL] [Abstract][Full Text] [Related]
31. External ultrasonography of the neck does not add diagnostic value to integrated positron emission tomography-computed tomography (PET-CT) scanning in the diagnosis of cervical lymph node metastases in patients with esophageal carcinoma.
Blom RL; Vliegen RF; Schreurs WM; Belgers HJ; Stohr I; Oostenbrug LE; Sosef MN
Dis Esophagus; 2012 Aug; 25(6):555-9. PubMed ID: 22150869
[TBL] [Abstract][Full Text] [Related]
32. The value of FDG positron emission tomography/computerised tomography (PET/CT) in pre-operative staging of colorectal cancer: a systematic review and economic evaluation.
Brush J; Boyd K; Chappell F; Crawford F; Dozier M; Fenwick E; Glanville J; McIntosh H; Renehan A; Weller D; Dunlop M
Health Technol Assess; 2011 Sep; 15(35):1-192, iii-iv. PubMed ID: 21958472
[TBL] [Abstract][Full Text] [Related]
33. PET and PET-CT in esophageal and gastric cancer.
Wieder HA; Krause BJ; Herrmann K
Methods Mol Biol; 2011; 727():59-76. PubMed ID: 21331929
[TBL] [Abstract][Full Text] [Related]
34. Metabolic information on staging FDG-PET-CT as a prognostic tool in the evaluation of 97 patients with gastric cancer.
Coupe NA; Karikios D; Chong S; Yap J; Ng W; Merrett N; Lin M
Ann Nucl Med; 2014 Feb; 28(2):128-35. PubMed ID: 24297388
[TBL] [Abstract][Full Text] [Related]
35. Multimodal imaging of esophagus and cardia cancer before and after treatment.
Fiore D; Baggio V; Ruol A; Bocus P; Casara D; Corti L; Muzzio PC
Radiol Med; 2006 Sep; 111(6):804-17. PubMed ID: 16896560
[TBL] [Abstract][Full Text] [Related]
36. Whole Body MRI in the Staging of Esophageal Cancer--A Prospective Comparison with Whole Body 18F-FDG PET-CT.
Malik V; Harmon M; Johnston C; Fagan AJ; Claxton Z; Ravi N; O'Toole D; Muldoon C; Keogan M; Reynolds JV; Meaney JF
Dig Surg; 2015; 32(5):397-408. PubMed ID: 26315570
[TBL] [Abstract][Full Text] [Related]
37. The incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of esophageal carcinoma.
Kato H; Miyazaki T; Nakajima M; Takita J; Kimura H; Faried A; Sohda M; Fukai Y; Masuda N; Fukuchi M; Manda R; Ojima H; Tsukada K; Kuwano H; Oriuchi N; Endo K
Cancer; 2005 Jan; 103(1):148-56. PubMed ID: 15558794
[TBL] [Abstract][Full Text] [Related]
38. Concordance of positron emission tomography and computed tomography in patients with locally advanced gastric and esophageal cancer.
Hocazade C; Özdemir N; Yazici O; Bozkaya Y; Yazılıtaş D; Toptaş Ş; Zengin N; Deren T
Ann Nucl Med; 2015 Aug; 29(7):621-6. PubMed ID: 26008856
[TBL] [Abstract][Full Text] [Related]
39. Reinterpretation of radiological findings in oesophago-gastric multidisciplinary meetings.
Lim HK; Stiven PN; Aly A
ANZ J Surg; 2016 May; 86(5):377-80. PubMed ID: 24674243
[TBL] [Abstract][Full Text] [Related]
40. Clinical staging of patients with early esophageal adenocarcinoma: does FDG-PET/CT have a role?
Cuellar SL; Carter BW; Macapinlac HA; Ajani JA; Komaki R; Welsh JW; Lee JH; Swisher SG; Correa AM; Erasmus JJ; Hofstetter WL
J Thorac Oncol; 2014 Aug; 9(8):1202-6. PubMed ID: 25157774
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
